|
|
News Breaks | | | | February 12, 2013 | | 13:01 EDT |  | A | Agilent enters strategic partnership with Sera Prognostics
Agilent Technologies (A) and Sera Prognostics Inc., a women's health company, announced a strategic partnership to develop proteomic assays for the early prediction of pregnancy complications. Sera Prognostics is currently developing a novel test for the early prediction of preterm birth risk using advanced proteomic science. Agilent is a leading provider of a wide range of analytical instrumentation, including liquid chromatography, mass spectrometry and automation systems. As part of the partnership, Sera Prognostics purchased multiple Agilent 1290 Infinity ultra high-performance liquid chromatography systems, 6490 iFunnel triple quadrupole mass spectrometry systems and 1260 Infinity LC systems with ultraviolet detectors and is adapting Agilent's automated sample-preparation technologies for production. The partners will develop high-throughput workflows for sample preparation and mass-spectrometry analysis. To meet the demands of high-volume testing, Sera Prognostics expects to leverage Agilent's novel automated sample-prep technology and other automation, including the AssayMAP Bravo and RapidFire fast liquid chromatography together with ultra-sensitive ion funnel triple quadrupole mass spectrometry. | |
|
News For A From The Last 14 Days Check below for free stories on A the last two weeks. |
|
|
| There are no results for A |
|
|
|
|
|
|
